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Abstract: Prenatal smoking exposure and early-life respiratory infections are major determinants of 
asthma during childhood. We investigate the factors influencing allergic sensitization (AS), asthma, 
and lung function in children and the balance between individual and environmental characteristics 
at different life stages. 1714 children aged 7–16 years and living in southern Italy were investigated 
using a parental questionnaire, skin prick tests, and spirometry. We found 41.0% AS prevalence: 
among children without parental history of asthma, male sex, maternal smoking during pregnancy 
(MatSmoke), and acute respiratory diseases in the first two years of life (ARD2Y) were significant 
risk factors for AS. MatSmoke was associated (OR = 1.79) with ARD2Y, and this association was 
influenced by sex. ARD2Y was, in turn, a significant risk factor (OR = 8.53) for childhood current 
asthma, along with AS (OR up to 3.03) and rhinoconjuctivitis (OR = 3.59). Forced mid-expiratory 
flow (FEF25–75%) was negatively affected by ARD2Y, with a sex-related effect. Thus, males exposed 
to MatSmoke had significantly lower FEF25–75% than unexposed males. Despite the difficulty of 
discriminating among the complex interactions underlying the development of allergic respiratory 
diseases, ARD2Y appears to strongly influence both asthma and lung function during childhood. In 
turn, ARD2Y is influenced by prenatal exposure to tobacco smoke with a sex-dependent effect. 
Keywords: cigarette smoking; child health; acute respiratory infections; allergic sensitization; 
asthma 
 
1. Introduction 
Asthma is the most common chronic childhood disease [1], and large variations in the 
prevalence of asthma and rhinitis symptoms in children have been reported worldwide [2]. In Italy, 
the SIDRIA (Italian Studies on Respiratory Disorders in Children and the Environment) Study, the 
largest Italian epidemiological survey of children, on the basis of questionnaire responses, reported 
a prevalence of 10.4% of lifetime asthma and 17.4% of rhinoconjunctivitis in the previous 12 months 
in 10,267 Italian adolescents [3], suggesting a trend towards a stabilization of asthma prevalence. 
Asthma is a common, heterogeneous, chronic respiratory disease affected by genetic, 
socioeconomic, and environmental factors [4]. Allergic sensitization is highly associated with the risk 
of respiratory symptoms among asthmatic children [5], and atopy increases the probability of allergic 
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asthma [4]. Among environmental factors, pre- and postnatal passive smoking exposure [6,7] along 
with early life respiratory infections [8] constitute the major determinants of asthma and poorer lung 
function during childhood. 
The present work investigates the factors influencing allergic sensitization, asthma, and lung 
function in children and the balance between individual characteristics and environmental exposures 
at different life stages: prenatal, early life, and childhood. To do this, we pooled data from two 
previous cross-sectional population studies performed in the Mediterranean area of southern Italy, 
which investigated respiratory and allergic symptoms, also objectively evaluating the respiratory 
function and the sensitization to most common aeroallergens. 
2. Materials and Methods 
2.1. Study Population 
A total of 2493 Caucasian Sicilian schoolchildren (primary and lower secondary school), aged 7–
16 years were pooled from two previous cross-sectional studies with nearly identical study designs: 
(i) Cibella et al. [9], n = 2150 from 16 schools (November 2005–May 2006); (ii) CCM-Indoor school project 
[10], n = 343 children from 8 schools (April 2012–April 2013). 
2.2. Questionnaires 
Parents of all 2493 investigated children completed a modified ISAAC (International Study of 
Asthma and Allergies in Childhood) questionnaire [11] regarding personal information and 
questions about past and current respiratory allergic symptoms and possible exposures. In both 
studies, the same core questions were used. The complete list of questions used in the analysis is the 
following: 
• Parental history of asthma 
Is there any case of asthma in the family? (mother or father) 
• Maternal smoking during pregnancy 
Did the mother smoke during pregnancy? (Yes/No) 
• Paternal smoking during pregnancy 
Did the father or other family members smoke in presence of the mother during her pregnancy? 
(Yes/No) 
• Early- life (during the first two years of life) exposure to environmental tobacco smoke (Early 
ETS) 
During the first two year of life, was your child exposed to tobacco smoke? (Yes/No) 
• Acute respiratory diseases during the first two years of life 
During the first two years of life, did your child suffer from any infections, such as pneumonia, 
bronchitis, asthmatic bronchitis, bronchiolitis? (Yes/No) 
• Wheeze in the last 12 months 
In the past 12 months, has your child had wheezing or whistling in the chest? (Yes/No) 
• Doctor diagnosed asthma 
Has your child ever had asthma diagnosed by a doctor? (Yes/No) 
• Nocturnal cough 
In the past 12 months, has your child had a dry cough at night, apart from a cough associated with 
a cold or chest infection? (Yes/No) 
• Exercise wheeze 
In the past 12 months, has your child’s chest sounded wheezy during or after exercise? (Yes/No) 
• Current exposure to tobacco smoke at home (ETS) 
Is your child exposed to tobacco smoke in the dwelling? (Yes if daily or often [1–4 times/week]) 
• Presence of mould/dampness at home 
Is there dampness or visible mould growth in your child’s bedroom? (Yes/No) 
• Pet ownership 
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Does the child, or any other family member, have any pets in the dwelling? (Yes/No) 
• Presence of heavy vehicular traffic in proximity to home 
Does your child live within 200 m of a street with heavy traffic? (Yes/No) 
• Rhinoconjunctivitis 
In the past 12 months, has your child had a problem with sneezing, or a runny or blocked nose when 
he/she did not have a cold or the flu, with this nasal problem being accompanied by itchy-watery eyes? 
(Yes/No) 
Moreover: 
• Current asthma was defined as a positive answer to both the questions relevant to Wheeze in 
the last 12 months and Doctor diagnosed asthma. 
• “Healthy” children were selected as those individuals without Doctor diagnosed asthma or 
without wheeze, nocturnal cough, exercise wheeze, or rhinoconjunctivitis in the last 12 months. 
2.3. Skin Prick Tests 
Skin prick tests were performed according to EAACI (European Academy of Allergy and 
Clinical Immunology) recommendations [12] with a standard panel including Dermatophagoides mix, 
Alternaria, Parietaria judaica, grass mix, Olea, Blattella germanica, dog and cat dander, plus a positive 
(histamine 1%) and a negative (saline) control (Stallergènes Italia S.r.l., Milan, Italy). The reading was 
performed after 15 min: reactions were considered positive if the mean wheal diameter (computed 
as the maximum diameter plus its orthogonal divided by 2) was 3 mm or greater, after having 
subtracted the wheal diameter of the reaction to the negative control. Allergic sensitization was 
defined as the presence of at least one positive skin prick test. The atopic index (AI) was computed 
as the number of the individual positive skin prick tests and divided into four classes: 0-non atopic, 
1-one positive skin test, 2-two positive skin tests, 3-three or more positive skin tests. 
2.4. Spirometry 
Height (in cm) and weight (in kg) were measured for all the children in standing position 
without shoes using a stadiometer and an electronic digital scale. BMI was computed as 
weight/height2 (kg/m2). Pulmonary function tests were performed with a portable spirometer 
(MicroLoop, Micro Medical, Chatham Maritime, Kent, UK). Forced expiratory volume in one second 
(FEV1), forced vital capacity (FVC) and maximum mid-expiratory flow (FEF25–75%) were measured 
according to ATS/ERS (American Thoracic Society/European Respiratory Society) guidelines [13]: the 
best FVC and FEV1 were retained and FEF25–75% was selected from the manoeuver with the largest 
sum of FEV1 and FVC. For each subject, FEV1/FVC and FEF25–75%/FVC ratios were also computed. 
Spirometric predicted values were those from Quanjer et al. [14]. Spirometric data were evaluated as 
z-scores. 
The studies were approved by the University Hospital of Palermo Ethics Committee on 8 
January 2007 and 18 May 2011. Parents of the invited schoolchildren signed written informed consent. 
According to Italian law, respect of individual privacy concerning clinical data was guaranteed. 
2.5. Statistics 
The normality of distribution of the continuous variables was evaluated by the Kolmogorov-
Smirnov Test. Continuous variables were expressed as means ± standard deviations (SD) and 
evaluated by one-way Analysis of Variance (ANOVA). Categorical variables were expressed as 
percentages and compared by means of the χ2 test. Multiple logistic regression models were used for 
investigating the effects of different variables on binary outcomes, taking into account confounders 
and effect modifying variables. These latter, were selected from the outdoor (residence in proximity 
to roads with intense vehicular traffic) and indoor (early and current exposure to environmental 
tobacco smoke, mould/dampness exposure at home, pet ownership) exposures known to possibly 
affect the evaluated outcome variables. Similarly, multiple linear regression models were created for 
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investigating the effects of different variables on continuous outcomes. p-Values < 0.05 were 
considered significant. 
Statistical analyses were performed by IBM SPSS statistics v20, IBM, New York, NY, USA. 
3. Results 
Out of 2493 total children, 1714 (F = 833, 48.6%) with complete data and parental questionnaires 
(68.9%) were evaluated. Descriptive and pulmonary function data of the population sample are 
shown in Table 1, for the overall sample and separately for subjects with and without current asthma. 
In our sample, 12.1% indicated maternal smoking during pregnancy, 31.9% reported the presence of 
acute respiratory diseases during the first two years of life (F/M: 29.2%/34.5%, p = 0.019), and 12.3% 
had positive parental asthma history. 
In a multiple logistic association model, male sex, maternal smoking during pregnancy, and 
parental history of asthma were positively associated with acute respiratory diseases during the first 
two years of life, while no effect was found for paternal smoking during pregnancy and early ETS 
exposure (Table 2). When compared to females unexposed to maternal smoking during pregnancy, 
the odds ratio (OR) for acute respiratory diseases during the first two years of life in exposed females 
was 2.09 (95% CI 1.34/3.26, Table 3), while the OR of exposed males was 2.06 (95% CI 1.31/3.25). 
Considering subjects without parental history of asthma (N = 1504), among children reporting 
acute respiratory diseases during the first two years of life, 44.7% presented allergic sensitization, 
while among children without acute respiratory diseases during the first two years of life, 37.2% (p = 
0.007) showed allergic sensitization. Among subjects with parental history of asthma (N = 210), the 
same figures were 53.0% and 51.2% (p = 0.80). In a multiple logistic model for allergic sensitization, 
the factors male sex, parental history of asthma, and acute respiratory diseases during the first two 
years of life were positively associated with allergic sensitization during childhood (Table 4). 
Stratifying the same logistic model for parental history of asthma, none of the previous variables were 
associated with allergic sensitization among children with parental history of asthma (Table 5). 
Conversely, among children without parental history of asthma, male sex, maternal smoking during 
pregnancy, and acute respiratory diseases during the first two years of life were positively associated 
with allergic sensitization (i.e., AI). 
In a separate multiple logistic model for current asthma, we tested the effect of previous (in utero 
and early-life) and current possible risk factors (Table 6): acute respiratory diseases during the first 
two years of life (OR = 8.53, 95% CI 4.15/17.52), rhinoconjunctivitis (OR = 3.59, 1.87/6.90), and allergic 
sensitization were positively associated with current asthma. In particular, AI class 1 produced an 
OR of 2.28 (95% CI 1.01/5.16), while class 3 was 3.03 (1.37/6.70). Consequently, the prevalence of 
current asthma in our sample progressively increased in the four AI classes, from 1.5% in class 0 up 
to 8.0% in class 3 (p for trend < 0.038). No effect was found between both current/past environmental 
exposures and current asthma. 
Table 1. Characteristics of study population. Significant p-Values are in bold. 
 
Overall Sample  
(N = 1714) 
Without Current 
Asthma  
(N = 1661) 
With Current 
Asthma  
(N = 53) 
p-Value † 
Males (%) 51.4 51.7 43.4 0.23** 
Age (mean ± SD) 11.6 ± 1.4 11.6 ± 1.4 11.8 ± 1.1 0.38* 
Height, m (mean ± SD) 1.51 ± 0.12 1.51 ± 0.12 1.54 ± 0.09 0.17* 
Weight, kg (mean ± SD) 48.8 ± 13.5 48.1 ± 13.4 51.6 ± 14.2 0.12* 
BMI, kg/m2 (mean ± SD) 21.1 ± 5.4 21.0 ± 5.4 21.6 ± 4.2 0.50* 
FEV1 (z-score, mean ± SD) 0.10 ± 1.05 0.11 ± 1.04 −0.22 ± 1.14 0.02* 
FVC (z-score, mean ± SD) −0.24 ± 1.03 −0.24 ± 1.03 −0.31 ± 1.14 0.62* 
FEV1/FVC (%, mean ± SD) 90.4 ± 5.8 90.4 ± 5.8 88.0 ± 7.5 0.003* 
FEF25–75% (z-score, mean ± SD) 0.14 ± 0.99 0.16 ± 0.98 −0.46 ± 1.04 <0.0001* 
FEF25–75%/FVC (mean ± SD) 1.12 ± 0.26 1.12 ± 0.26 0.99 ± 0.25 0.0002* 
Exposed to maternal smoke during 
pregnancy (%) 
12.1 12.0 15.1 0.50** 
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Exposed to paternal smoke during 
pregnancy (%) 
40.3 40.3 41.5 0.85** 
Exposure to environmental tobacco smoke 
during the first two years of life (%) 
24.7 24.5 32.1 0.21** 
Acute respiratory diseases during the first 
two years of life (%) 
31.9 24.5 32.1 0.21** 
Positive parental history of asthma (%) 12.3 11.5 35.8 <0.0001** 
Current exposure to tobacco smoke at home 
(%) 
46.8 46.5 54.7 0.24** 
Presence of mould/dampness at home (%) 10.5 10.5 11.5 0.81** 
Pet ownership (%) 21.9 21.8 24.5 0.63** 
Presence of heavy vehicular traffic in 
proximity to home (%) 
23.6 23.6 22.6 0.87** 
Wheeze in the last 12 months (%) 6.3 3.3 100.0 <0.0001** 
Doctor diagnosed asthma (%) 9.6 6.6 100.0 <0.0001** 
Rhinoconjunctivitis (%) 11.1 10.2 41.5 <0.0001** 
Allergic sensitization (%) 41.0 40.0 71.7 <0.0001** 
No sensitization (%) 59.0 60.0 28.3 
<0.0001** 
One positive skin prick test (%) 17.0 16.7 24.5 
Two positive skin prick tests (%) 10.5 10.4 13.2 
Three or more positive skin prick tests (%) 13.5 12.9 34.0 
† p-Value computed for the differences between subjects with and without current asthma; * one-way 
ANOVA; ** χ2 test. 
Table 2. Multiple logistic association model for acute respiratory diseases in the first two years in the 
overall study population (n = 1714). OR: Odds Ratio. Significant p values are in bold. 
Independent Variables OR 
95% Confidence Interval p-Value 
Lower Upper  
Education level (Ref.: higher) 0.821 0.660 1.022 0.078 
Sex (Ref: Female) 1.282 1.038 1.593 0.0214 
Exposure to maternal smoke during pregnancy (Ref.: not exposed) 1.792 1.295 2.479 0.0004 
Paternal smoke during pregnancy (Ref.: not exposed) 0.874 0.680 1.122 0.291 
Early exposure to environmental tobacco smoke (Ref.: not exposed) 1.167 0.879 1.548 0.286 
Positive parental history of asthma (Ref.: negative) 1.516 1.113 2.065 0.008 
Table 3. Multiple logistic association model for acute respiratory diseases in the first two years in the 
overall study population. In this table, four combinations of exposure to maternal smoke during 
pregnancy and sex were separately evaluated. OR: Odds Ratio. Significant p values are in bold. 
Independent Variables OR 
95% Confidence Interval p-Value 
Lower Upper  
Education level (Ref.: higher) 0.822 0.661 1.023 0.079 
Paternal smoke during pregnancy (Ref.: not exposed) 0.869 0.677 1.117 0.273 
Early exposure to environmental tobacco smoke (Ref.: not exposed) 1.174 0.884 1.559 0.267 
Positive parental history of asthma (Ref.: negative) 1.508 1.107 2.055 0.009 
Not exposed to maternal smoke during pregnancy * male sex † 1.342 1.065 1.690 0.013 
Exposed to maternal smoke during pregnancy * male sex † 2.061 1.308 3.249 0.002 
Exposed to maternal smoke during pregnancy * female sex † 2.088 1.335 3.263 0.001 
† Ref.: Not exposed to maternal smoke during pregnancy * female sex. 
Table 4. Multiple logistic association model for allergic sensitization in the overall study population 
(n = 1714). OR: Odds Ratio. Significant p-Values are in bold. 
Independent variables OR 
95% Confidence Interval p-Value 
Lower Upper  
Education level (Ref.: higher) 1.047 0.847 1.295 0.669 
Sex (Ref.: females) 1.483 1.207 1.822 0.0002 
Positive parental history of asthma (Ref.: negative) 1.629 1.199 2.215 0.002 
Maternal smoke during pregnancy (Ref.: not exposed) 1.378 0.989 1.920 0.058 
Paternal smoke during pregnancy (Ref.: not exposed) 1.150 0.886 1.493 0.294 
Early exposure to environmental tobacco smoke (Ref.: not exposed) 1.031 0.783 1.359 0.826 
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Acute respiratory diseases in the first two years (Ref.: not reported) 1.292 1.036 1.611 0.023 
Current exposure to environmental tobacco smoke (Ref.: not reported) 0.921 0.718 1.181 0.515 
Residence in proximity to roads with intense vehicular traffic (Ref.: not 
reported) 
0.957 0.749 1.223 0.723 
Mould/dampness at home (Ref.: not reported) 0.899 0.643 1.256 0.533 
Pet ownership (Ref.: not reported) 0.923 0.718 1.186 0.532 
Table 5. Multiple logistic association model for allergic sensitization, separately for subjects with and 
without parental history of asthma. OR: Odds Ratio; 95% CI: 95% confidence interval. Significant p-
Values are in bold. 
 
Subjects with Parental History of 
Asthma  
(N = 210) 
Subjects without Parental History of 
Asthma  
(N = 1504) 
Independent variables † OR 
95% CI p-
Value 
OR 
95% CI 
p-Value 
Lower Upper Lower Lower 
Education level 1.007 0.544 1.861 0.984 1.053 0.839 1.322 0.653 
Sex 1.158 0.643 2.083 0.625 1.527 1.225 1.905 0.0002 
Maternal smoke during 
pregnancy  
0.673 0.268 1.689 0.399 1.537 1.076 2.194 0.018 
Paternal smoke during 
pregnancy  
1.282 0.649 2.530 0.474 1.137 0.855 1.511 0.376 
Early exposure to 
environmental tobacco 
smoke 
1.065 0.489 2.316 0.875 1.024 0.761 1.378 0.874 
Acute respiratory diseases 
in the first two years 
1.022 0.562 1.857 0.944 1.353 1.066 1.718 0.013 
Current exposure to 
environmental tobacco 
smoke 
1.066 0.546 2.083 0.851 0.915 0.698 1.198 0.518 
Residence in proximity to 
roads with intense 
vehicular traffic 
0.883 0.443 1.758 0.723 0.976 0.750 1.271 0.859 
Mould/dampness at home 1.446 0.549 3.808 0.455 0.842 0.587 1.209 0.352 
Pet ownership 1.138 0.583 2.220 0.705 0.890 0.677 1.169 0.402 
† Refer to Table 4 for reference levels. 
Table 6. Multiple logistic association model for current asthma in the overall study population (n = 
1714). OR: Odds Ratio. Significant p-Values are in bold. 
Independent Variables OR 
95% Confidence 
Interval 
p-
Value 
Lower Upper  
Education level (Ref.: higher) 1.042 0.561 1.932 0.897 
Sex (Ref.: Female) 0.531 0.286 0.988 0.046 
Maternal smoke during pregnancy (Ref.: not exposed) 0.900 0.380 2.132 0.811 
Paternal smoke during pregnancy (Ref.: not exposed) 0.797 0.371 1.713 0.561 
Early exposure to environmental tobacco smoke (Ref.: not 
exposed) 
1.490 0.683 3.251 0.317 
Acute respiratory diseases in the first two years (Ref.: not 
reported) 
8.526 4.150 17.516 <0.0001 
Rhinoconjunctivitis (Ref.: not reported) 3.590 1.868 6.901 0.0001 
Current exposure to environmental tobacco smoke (Ref.: not 
reported) 
1.191 0.571 2.484 0.642 
Residence in proximity to roads with intense vehicular traffic 
(Ref.: not reported) 
0.933 0.449 1.936 0.852 
Mould/dampness at home (Ref.: not reported) 0.810 0.315 2.085 0.662 
Pet ownership (Ref.: not reported) 0.930 0.454 1.903 0.842 
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One positive skin prick test (Ref.: no sensitization) 2.283 1.010 5.159 0.047 
Two positive skin prick tests (Ref.: no sensitization) 2.041 0.762 5.465 0.156 
Three or more positive skin prick tests (Ref.: no sensitization) 3.025 1.367 6.695 0.006 
BMI (kg/m2) 0.995 0.933 1.061 0.876 
In a multiple linear regression model for FEF25–75% (as z-score), acute respiratory diseases during 
the first two years of life and current asthma were negatively correlated with FEF25–75%, and different 
combinations of sex and maternal smoking during pregnancy provided different results (Table 7): 
the model provided a B coefficient of −0.38 (95% CI −0.60/−0.15) for male sex and exposure to maternal 
smoking during pregnancy with respect to male children unexposed to maternal smoking during 
pregnancy, whereas exposed females showed a B coefficient of −0.24 (95% CI −0.46/−0.03). 
Consequently, the same four combinations of sex and exposure to maternal smoking during 
pregnancy produced significantly different levels of FEF25–75% (z-score) between male children 
exposed or not to maternal smoking during pregnancy, but not among females (Figure 1). When 
stratifying the multiple linear regression for sex, any significant effect of exposure to maternal 
smoking during pregnancy among females disappeared (Table S1A,B in Supplementary Material). 
Moreover, it is noteworthy that, in the same model including only the 1102 “healthy” individuals, 
FEF25–75% was still negatively correlated to both acute respiratory diseases during the first two years 
of life and to maternal smoking during pregnancy (Table S2 in Supplementary Material). 
A similar model was built for FEF25–75%/FVC ratio (Table S3, in Supplementary Material): the 
different combinations of sex and exposure to Maternal smoking during pregnancy produced very 
similar B values for females, while males exposed to Maternal smoking during pregnancy presented 
a more negative B value (−0.189 [95% CI −0.247/−0.131]) than males unexposed to maternal smoking 
during pregnancy (−0.106 [95% CI −0.134/−0.079)]. 
 
Figure 1. Means (± SD) of FEF25–75% (z-score) separately by sex and exposure to maternal smoke during 
pregnancy. Differences were evaluated by means of one-way ANOVA and Fisher’s LSD. 
Table 7. Multiple linear regression model for FEF25–75% (as z-score) in the overall study population (n 
= 1714). Four combinations of exposure to maternal smoke during pregnancy and sex were separately 
evaluated. Significant p-Values are in bold. 
Independent Variables B 
95% Confidence 
Interval 
p 
Value 
Lower Upper  
Education level (Ref.: higher) −0.009 −0.111 0.092 0.856 
Early exposure to environmental tobacco smoke (Ref.: not 
exposed) 
0.098 −0.025 0.222 0.118 
Acute respiratory diseases in the first two years (Ref.: not 
reported) 
−0.270 −0.379 −0.161 <0.0001 
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Nocturnal cough (Ref.: not reported) 0.017 −0.107 0.141 0.792 
Current asthma (Ref.: not reported) −0.431 −0.733 −0.130 0.005 
Exercise wheezing (Ref.: nor reported) −0.081 −0.343 0.181 0.545 
Rhinoconjunctivitis (Ref.: nor reported) −0.124 −0.287 0.039 0.135 
Current exposure to environmental tobacco smoke (Ref.: not 
reported) 
0.064 −0.045 0.172 0.249 
Residence in proximity to roads with intense vehicular traffic 
(Ref.: not reported) 
0.080 −0.038 0.198 0.183 
Mould/dampness at home (Ref.: not reported) 0.033 −0.127 0.193 0.685 
Pet ownership (Ref.: not reported) 0.032 −0.087 0.151 0.595 
Allergic sensitization (Ref.: negative) 0.089 −0.014 0.191 0.089 
Weight (kg) 0.004 0.000 0.008 0.032 
Not exposed to maternal smoke during pregnancy * female sex 
† 
−0.103 0.208 0.002 0.054 
Exposed to maternal smoke during pregnancy * female sex 
† −0.243 −0.460 −0.026 0.028 
Exposed to maternal smoke during pregnancy * male sex 
† −0.375 −0.596 −0.154 0.001 
† Ref.: not exposed to maternal smoke during pregnancy * male sex. 
4. Discussion 
This cross-sectional study conducted on a sample of 1714 adolescents from the Mediterranean 
area of southern Italy was aimed at investigating factors influencing allergic sensitization, asthma, 
and lung function in children including individual characteristics and environmental exposures at 
different life stages (prenatal, early life, childhood). 
We found that in utero exposure to maternal smoke produces an increased prevalence of acute 
respiratory disease during the first two years of life. Both exposure to maternal smoke during 
pregnancy and acute respiratory diseases during the first two years of life, in turn, affect–directly or 
indirectly–allergic sensitization, asthma prevalence, and lung function during adolescence, with a 
sex-dependent effect. 
4.1. Acute Respiratory Diseases in the First Two Years of Life 
We found that a parental history of asthma was a significant independent risk factor for acute 
respiratory diseases during the first two years of life [15], with atopy in synergy with recurrent early-
life respiratory infections for higher prevalence of later asthma [16]. In the present work, sensitivity 
to Maternal smoking during pregnancy was similar between the sexes, although–among non exposed 
babies–the risk of acute respiratory diseases during the first two years of life was higher in males. 
Nevertheless, both males and females exposed to maternal smoking during pregnancy showed more 
than twice the risk (ORs 2.06 and 2.09, respectively) of having acute respiratory diseases during the 
first two years of life with respect to unexposed females, confirming the role of maternal smoking 
during pregnancy as a significant factor for increased risk of hospital admission for acute upper and 
lower respiratory infections, asthma, and bronchiolitis [17]. It has been suggested that maternal 
smoking during pregnancy negatively influences lung function in the newborn [18,19], while the 
effects on bronchial hyperresponsiveness remain uncertain [20,21]. Exposure to maternal smoking 
during pregnancy could also damage the epithelium impairing defense mechanisms and thus 
increasing susceptibility to pathogens [22]. We found an overall significant effect of sex on acute 
respiratory diseases during the first two years of life: this is probably due to the fact that, at birth, the 
lungs of boys are larger than those of girls [23], while maturation is more advanced in females. Thus, 
at birth, females have a more favorable airway/lung size ratio, while males present disproportionate 
growth (“dysanapsis”) between airways and air spaces [24], predisposing infants to developing 
bronchial obstruction during viral respiratory infections early in life [25]. 
4.2. Allergic Sensitization 
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We found that exposure to maternal smoking during pregnancy and male sex were significant 
risk factors for allergic sensitization during childhood. While the association between male sex and 
atopy up to puberty is well known [26,27], the relationship between maternal smoking during 
pregnancy and allergic sensitization is controversial. We found no significant effect of maternal 
smoking during pregnancy on allergic sensitization in children with parental history of asthma. 
Conversely, a previous work has reported that maternal smoking during pregnancy is a strong risk 
factor for allergic sensitization and asthma symptoms during the first 10 years of life, but only in 
children with allergic parents [28]; more recently, no clear associations were found between maternal 
smoking during pregnancy and atopic sensitization [29]. 
A further strong risk factor for allergic sensitization was acute respiratory diseases during the 
first two years of life. In this regard, the result obtained by stratifying children for parental history of 
asthma is interesting. Similarly to what was observed for maternal smoking during pregnancy, we 
found that among subjects without a parental history of asthma, acute respiratory diseases during 
the first two years were associated with a higher prevalence of allergic sensitization. Conversely, this 
result was not found in children reporting a positive family history of asthma. Thus, we suppose that 
the strong effect of parental history of asthma – when present – is able to hide the effects of acute 
respiratory diseases during the first two years of life on allergic sensitization. Despite the hypothesis 
that allergic sensitization increases the risk for early-life respiratory infections and not the inverse 
[15], our results suggest that acute respiratory diseases during the first two years of life produce their 
effect on future allergic sensitization mainly in subjects with apparently lower genetic predisposition 
(i.e., lack of parental history of asthma). However, it has to be acknowledged that the latter result 
could be influenced by the limited number (N = 210) of subjects who reported a parental history of 
asthma. 
4.3. Current Asthma 
In our study, current asthma was defined as the contemporary presence of doctor diagnosed 
asthma and wheeze in the last 12 months. In a multiple logistic model, acute respiratory diseases 
during the first two years of life, rhinoconjunctivitis and allergic sensitization were independent risk 
factors for current asthma. It was previously demonstrated that the presence of rhinoconjunctivitis 
can strongly increase the risk of current asthma [30]. As expected, at least in Western countries [31], 
increasing levels of AI produced a progressively increased asthma risk: nevertheless, it is noteworthy 
that acute respiratory diseases during the first two years of life produced a greater current asthma 
risk (OR= 8.53 [95%IC 4.15/17.52]) than the highest level of AI (OR = 3.03 [95%IC 1.37/6.70]), 
corresponding to individuals with at least three allergic sensitizations. In this model, males showed 
a lower current asthma risk than females (p = 0.046, Table 6). In fact, as age increases, asthma 
prevalence decreases in male subjects [32]. 
Despite the fact that allergic sensitization was more frequent among males and that male sex 
was protective against current asthma (Table 6), we did not find sex-related differences in prevalence 
rates of current asthma or rhinoconjunctivitis. This could be due to the known changes in asthma 
prevalence between females and males during puberty [33]. Thus, in our opinion, the cited 
disproportion between airways and air spaces present at birth between male and female babies 
continues producing its effects during childhood in terms of different responses to previous 
exposures (maternal smoking during pregnancy) and to atopy (allergic sensitization and 
Rhinoconjunctivitis), adding their effects to the sex-related differences in asthma over the lifespan 
[33]. 
4.4. Lung Function 
We chose to use FEF25–75% as a sensitive indicator of airway obstruction also in asymptomatic 
children [34]. In a multiple linear regression for FEF25–75%, we found that the occurrence of acute 
respiratory diseases during the first two years of life was correlated to poorer lung function. Males 
exposed to maternal smoking during pregnancy presented a highly negative B value (−0.375 [95% CI 
−0.596/−0.154], p = 0.001, Table 7) with respect to the combination of no exposure to maternal smoking 
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during pregnancy and male sex. The remaining two combinations showed intermediate–but still 
significant–negative B values. This result suggests a sex-dependent sensitivity to maternal smoking 
during pregnancy exposure: in fact, when stratified by sex, the same multiple regression model 
provided different results. Acute respiratory diseases during the first two years of life significantly 
decreased FEF25–75% during childhood in both females and males. In addition, only among males was 
FEF25–75% also dependent on maternal smoking during pregnancy (Table S1A,B, in Supplemental 
Material). This latter result was not confirmed for females, in agreement with previous reports 
indicating that maternal smoking during pregnancy has an effect on child lung function, but only in 
males [35]. In our sample, male children showed lower FEF25–75%/FVC ratio values than females, 
indicating that some inequalities between the geometry of the tracheobronchial tree and lung 
parenchyma may exist in male children with respect to females [36]. This seems to be confirmed by 
the results of the multiple regression for FEF25–75%/FVC ratio: exposure to maternal smoking during 
pregnancy negatively influenced males but not females. Finally, by evaluating “healthy” children 
only (i.e., children without respiratory symptoms), we found that exposure to maternal smoking 
during pregnancy and acute respiratory diseases during the first two years of life maintained their 
negative effect on lung function, even in those without any history of lower airway disease. This is in 
agreement with previous results showing that prenatal exposure to maternal smoking during 
pregnancy [35] and early-life lower respiratory tract infections [37] are associated with poorer lung 
function later in life. 
4.5. Strengths and Limitations 
The main strength of the present work is its comprehensive and simultaneous evaluation of 
many possible factors that, from in utero life to adolescence, may affect allergic sensitization and 
allergic diseases. 
This work also presents some limitations. The reports relevant to parental smoking exposure 
during pregnancy are retrospective, thus they may be subject to recall bias. A more serious weakness 
is the lack of information on pregnancy duration, birthweight, and breastfeeding duration, which are 
known to significantly influence the outcome variables evaluated in this study. Nevertheless, it has 
been suggested that birthweight and gestational age may not be associated with lung function later 
in life [38]. However, the associations regarding sex-related differences and pre- and postnatal factors 
were obtained by means of an objective evaluation of individual allergic sensitization and lung 
function. Thus, these may provide useful additional insights on childhood asthma determinants. A 
further limitation of this study is the parental report of wheeze, which may be subject to 
misclassification. However, the core questions used represent the standard ISAAC measure for 
respiratory outcomes and have been shown to be predictive of doctor diagnosed asthma [11]. 
5. Conclusions 
We confirm that acute respiratory diseases during the first two years of life–which appear to be 
influenced by a parental history of asthma–strongly influence both asthma and poorer lung function 
during childhood. Infections may compromise epithelial integrity, especially during early lung 
maturation phases, in turn facilitating sensitization to aeroallergens [39]. Thus, it is difficult to 
discriminate among all the complex interactions underlying the development of allergic respiratory 
diseases, and conditioning lung function, including both preventable and genetic factors (Figure 2). 
In particular, by means of a logistic association model stratified for parental history of asthma, we 
found that the prevalence of acute respiratory diseases during the first two years of life and exposure 
to maternal smoking during pregnancy–along with male sex–were significantly associated with 
allergic sensitization during childhood in the absence of a family history of allergic diseases. This 
strongly suggests that, without a genetic tendency to develop allergic diseases (i.e., the lack of 
parental history of asthma), exposure to maternal smoking during pregnancy and the occurrence of 
acute episodes of respiratory diseases in early life may act as strong independent risk factors for 
allergic sensitization. This, in turn, produces increased risk for allergic respiratory diseases. 
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Figure 2. Schematic representation of the complex interactions underlying the development of acute 
respiratory diseases during the first two years of life and allergic respiratory diseases, as well as 
conditioning lung function, including both preventable and genetic factors. 
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